About

David Mascarella

Founder of Hyperuranios.
Twenty-five years as operator in enterprise software.

David Mascarella

David Mascarella, Bergamo · 2026.

The operator behind the practice

A practice built from twenty-five years of running real businesses.

David Mascarella is the founder of Hyperuranios. His operating background spans more than twenty-five years as founder and leader in enterprise software, starting in 2002 with 4ward (today 4wardpro), the Microsoft-ecosystem system integrator he founded and led across roles including CEO, CFO, and CRO. The discipline of analytical reasoning and rigorous strategy that defines Hyperuranios was forged there — in real P&Ls, not in consulting frameworks.

He has been with CoreView since 2015, as co-founder and Board Member. Through the company's first three years — from 2015 to early 2018 — he held Co-CEO (with the other founder), Chief Product Officer, and Chief Revenue Officer in parallel. A rare configuration: product and revenue ownership held singly, chief executive responsibility shared with the co-founder, the trade-offs of a scaling business resolved at the same table by the same hands.

From March 2018 he stepped out of the CRO role and held Chief Product Officer and Chief Global Strategist. In that period he authored the majority of the platform features that defined product-market fit and sticky retention. His work has consistently focused on the discipline of problem definition — understanding what customers, markets, and organizations actually need before designing the response.

Multiple exits in enterprise technology have refined his perspective on the founder, board, and investor sides of value creation. He is currently Strategic & Post-Sales Advisor and Founder at CoreView, alongside his role as Board Member.

Hyperuranios is the natural form of that practice — applied selectively, with capital and operator commitment where it can compound.

A transformation, told in four acts

Restructuring CoreView's post-sales.

Twenty-eight months between diagnosis and outcome. The case is recent, the pattern is structural, and the scaling is ongoing. Read it as one operating example of the discipline applied at full extension.

Jan 2024

The diagnosis.

Took over the existing customer success organization. The brief in the room was the conventional one — "improve customer success." The real problem was different and structural: the post-sales function was not perceived as a trusted technical advisor by enterprise customers. Trust, retention, and expansion were all symptoms of that single underlying gap. Problems before solutions applied to the team handed over.

Oct 2024

The decision.

Structural redesign of the team — from a customer-success-led model to a technical-advisor-led model. The post-sales engagement was rebuilt around technical depth as the trust mechanism, not around relationship management. Adding more CSMs would have scaled the wrong shape; the answer was to change the shape.

Jan 2025

The accountability.

Took quota ownership for expansion personally. Direct commercial accountability on the numbers the new model was supposed to produce — not as observer, not as designer, but as owner. Commit, then exceed applied to oneself: design the structural change, then carry the commercial risk of the structural change.

2026 →

The compounding.

Eighteen months after the structural decision, the new model delivered double-digit improvements in both gross dollar retention and net revenue retention. CoreView is now expanding the technical advisor team further — the strongest possible external validation, at the cost of additional headcount the company chose to commit.

The outcome

One team. One redesign. Eighteen months.
Retention and expansion compounded structurally — not motivated quarterly.

Twenty-five years of operating practice,
applied selectively.

Hyperuranios takes on a small number of engagements at a time. Conversations begin in confidence, and continue only when the problem is one where the practice can materially shape the outcome.